31st Edition Strategic Project & Portfolio Management for Pharma

The Marcus Evans 31st Edition Strategic Project & Portfolio Management for Pharma conference will explore how European pharmaceutical PMO and portfolio leaders can strengthen prioritisation, reinforce decision independence, and improve data readiness across the portfolio. Sessions will highlight governance approaches that keep decision review rigorous and independent, the discipline to invest, wait, or stop across every pipeline stage, a single trusted source of truth for portfolio data, and where AI and agile can genuinely add value to portfolio decisions. The agenda will also deliver practical guidance on resource allocation and final decision authority within matrix organisations, helping PPM leaders close the gap between portfolio planning, governance, resourcing, and delivery. Delegates will leave with actionable frameworks to strengthen PPM’s influence and impact across their organisation.

Topics Covered:

Challenge leadership bias in asset valuation to protect pharma R&D portfolio decisions
Rebalance early and late-stage assets under EU HTA and market access pressure
Rebalance the pipeline across early and late-stage assets under EU HTA pressure
Build trust in AI-assisted pharma R&D portfolio decisions under the EU AI Act
Build a pharma R&D PMO Centre of Excellence that withstands leadership and organisational change
Extend PPM accountability beyond governance approval to keep asset decisions on track through development

Past speakers include:

Thorsten Knoechel, Head of R&D Governance Operations, Merck, Germany
Ullas Hiremath, Director- Early Portfolio & Pipeline, Sandoz, Germany
Vincenzo Garzya, Data Science and Artificial Intelligence Head of Business Planning, Strategy & Operations, AstraZeneca, UK
Bence Tuske, Head of Program Management, Sanofi,Hungary
George Mouzakis, Global Pipeline Planning Director - Cardio/Renal/Metabolic, Neuroscience & Gene Therapies Dev. Units, Novartis, Switzerland
Carolina Bernhardt, Global Marketing and Value Lead Inflammation Indication Strategies, Boehringer Ingelheim, Germany

Special discounts available to pharmaphorum members! For more information please contact: Stefanos Ioannou, Digital Media and PR Executive at stefanosi@marcusevanscy.com or visit: https://tinyurl.com/mr9n9wfv